Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...
Total net sales for Q1 2025 were $5.1 million, reflecting a 12% sequential increase from the prior quarter. E-commerce sales contributed $3.9 million, representing 77% of total net sales, while ...
Inside a lab in South Korea, a rainbow-colored glint caught the eye of a graduate student. This gleam is the product of ...